Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients - PubMed (original) (raw)
. 2006 Oct;17(10):1506-13.
doi: 10.1007/s00198-006-0154-6. Epub 2006 Aug 5.
Affiliations
- PMID: 16896512
- DOI: 10.1007/s00198-006-0154-6
Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients
M Inaba et al. Osteoporos Int. 2006 Oct.
Abstract
Introduction: Fibroblast growth factor (FGF) 23 is a recently identified circulating factor that regulates phosphate (Pi) metabolism. Since the derangement of Pi control is an important risk factor for vascular calcification, we investigated the importance of plasma FGF-23 in the development of vascular calcification in the aorta and peripheral artery in hemodialysis patients with and without diabetes mellitus (DM).
Methods: Male hemodialysis patients with DM (n=32) and without DM (n=56) were examined. Plasma samples were obtained before the start of dialysis sessions, and the FGF-23 levels were determined by enzyme-linked immunosorbent assay. Roentgenography of the aorta and hand artery was performed, and visible vascular calcification was evaluated by one examiner, who was blinded to the patient characteristics.
Results: In the 56 non-DM hemodialysis patients, vascular calcification was found in the hand artery in 5 patients (8.9%) and in the aorta in 23 patients (41.1%). These levels were significantly lower (p<0.05) than in the 32 DM patients, of whom, 19 (59.4%) and 21 (65.6%) had vascular calcification of the hand artery and aorta, respectively. Multiple regression analyses performed separately in the non-DM and DM patients showed that the plasma FGF-23 level, CaxPi product, and body weight are independent factors significantly associated with hand-artery calcification and that diastolic blood pressure is associated with aorta calcification in non-DM patients. In DM patients, the plasma FGF-23 level and hemodialysis duration emerged as independent factors associated with hand-artery calcification and diastolic blood pressure was associated with aorta calcification. The independent association of the plasma FGF-23 level with hand-artery calcification was retained in both non-DM and DM patients when adjusted for the CaxPi product.
Conclusion: Our findings show that the plasma FGF-23 level is an independent factor negatively associated with peripheral vascular calcification in the hand artery, but not in the aorta, in both male non-DM and DM hemodialysis patients, even when adjusted for the CaxPi product. This study raises the possibility that the plasma FGF-23 level may provide a reliable marker for Moenckeberg's medial calcification in male hemodialysis patients, independent of its regulatory effect on Pi metabolism.
Similar articles
- Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
Kojima F, Uchida K, Ogawa T, Tanaka Y, Nitta K. Kojima F, et al. Int Urol Nephrol. 2008;40(4):1067-74. doi: 10.1007/s11255-008-9462-4. Epub 2008 Sep 13. Int Urol Nephrol. 2008. PMID: 18791804 - Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.
Balci M, Kirkpantur A, Gulbay M, Gurbuz OA. Balci M, et al. Hemodial Int. 2010 Oct;14(4):425-32. doi: 10.1111/j.1542-4758.2010.00480.x. Hemodial Int. 2010. PMID: 20955275 - Vascular calcification in maintenance hemodialysis patients.
Wang M, Wang M, Gan LY, Li SJ, Hong N, Zhang M. Wang M, et al. Blood Purif. 2009;28(1):15-20. doi: 10.1159/000210033. Epub 2009 Mar 27. Blood Purif. 2009. PMID: 19325235 - Aortic calcification.
Jayalath RW, Mangan SH, Golledge J. Jayalath RW, et al. Eur J Vasc Endovasc Surg. 2005 Nov;30(5):476-88. doi: 10.1016/j.ejvs.2005.04.030. Epub 2005 Jun 15. Eur J Vasc Endovasc Surg. 2005. PMID: 15963738 Review. - Aortic arch calcification and mortality in chronic hemodialysis patients.
Nitta K, Ogawa T. Nitta K, et al. Rev Recent Clin Trials. 2010 Sep;5(3):133-7. doi: 10.2174/157488710792007266. Rev Recent Clin Trials. 2010. PMID: 20455869 Review.
Cited by
- Fibroblast Growth Factor-23 in Pre-Dialysis Chronic Kidney Disease Patients and its Correlation with Carotid Artery Calcification.
Kumar T, Mohanty S, Rani A, Malik A, Kumar R, Bhashker G. Kumar T, et al. Indian J Nephrol. 2022 Nov-Dec;32(6):560-566. doi: 10.4103/ijn.IJN_506_20. Epub 2022 Nov 21. Indian J Nephrol. 2022. PMID: 36704592 Free PMC article. - FGF23 and Cardiovascular Structure and Function in Advanced Chronic Kidney Disease.
Halim A, Burney HN, Li X, Li Y, Tomkins C, Siedlecki AM, Lu TS, Kalim S, Thadhani R, Moe S, Ting SMS, Zehnder D, Hiemstra TF, Lim K. Halim A, et al. Kidney360. 2022 Jul 5;3(9):1529-1541. doi: 10.34067/KID.0002192022. eCollection 2022 Sep 29. Kidney360. 2022. PMID: 36245643 Free PMC article. - Arrhythmias in Chronic Kidney Disease.
Akhtar Z, Leung LW, Kontogiannis C, Chung I, Bin Waleed K, Gallagher MM. Akhtar Z, et al. Eur Cardiol. 2022 Mar 7;17:e05. doi: 10.15420/ecr.2021.52. eCollection 2022 Feb. Eur Cardiol. 2022. PMID: 35321526 Free PMC article. Review. - Fibroblast Growth Factor 23 as Regulator of Vitamin D Metabolism.
Nakatani S, Nakatani A, Mori K, Emoto M, Inaba M, Razzaque MS. Nakatani S, et al. Adv Exp Med Biol. 2022;1362:47-54. doi: 10.1007/978-3-030-91623-7_6. Adv Exp Med Biol. 2022. PMID: 35288872 - Paradoxical positive association of serum adiponectin with all-cause mortality based on body composition in Japanese haemodialysis patients.
Machiba Y, Inaba M, Mori K, Kurajoh M, Nishide K, Norimine K, Yamakawa T, Shoji S, Okuno S. Machiba Y, et al. Sci Rep. 2018 Oct 2;8(1):14699. doi: 10.1038/s41598-018-33011-y. Sci Rep. 2018. PMID: 30279489 Free PMC article.
References
- J Clin Endocrinol Metab. 1997 Feb;82(2):674-81 - PubMed
- Semin Nephrol. 2004 Sep;24(5):408-12 - PubMed
- Clin Chem. 2004 Feb;50(2):385-90 - PubMed
- J Clin Endocrinol Metab. 2004 Sep;89(9):4489-92 - PubMed
- Osteoporos Int. 2005 May;16(5):517-25 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous